President & CEO of Fluidigm Corp (30-Year Financial, Insider Trades) Stephen Christopher Linthwaite (insider trades) sold 84,820 shares of FLDM on 11/23/2020 at an average price of $6.06 a share. The total sale was $514,009.
Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies. Fluidigm Corp has a market cap of $427.660 million; its shares were traded at around $5.77 with and P/S ratio of 3.26. Fluidigm Corp had annual average EBITDA growth of 7.60% over the past ten years. GuruFocus has detected 5 severe warning signs with Fluidigm Corp. .
- Warning! GuruFocus has detected 5 Warning Signs with FLDM. Click here to check it out.
- FLDM 30-Year Financial Data
- The intrinsic value of FLDM
- Peter Lynch Chart of FLDM
CEO Recent Trades:
- President & CEO Stephen Christopher Linthwaite sold 84,820 shares of FLDM stock on 11/23/2020 at the average price of $6.06. The price of the stock has decreased by 4.79% since.
For the complete insider trading history of FLDM, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.